A Study to Learn About the Outcomes Between Study Medicines, Enzalutamide and Darolutamide Among Men With Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Clinical trial NCT07779590 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07779590
- Sponsor
- Pfizer
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-09-01
- Primary completion
- 2026-11-15
- Enrollment
- 4700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.